Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Mersana Therapeutics Inc shares valued at $16,178 were sold by DeSchuytner Brian on Oct 02 ’24. At $2.00 per share, DeSchuytner Brian sold 8,089 shares. The insider’s holdings dropped to 100,422 shares worth approximately $0.19 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, DeSchuytner Brian sold 5,598 shares, netting a total of over 10,972 in proceeds. Following the sale of shares at $1.96 each, the insider now holds 94,824 shares.
Before that, Carvajal Alejandra had sold 8,089 shares from its account. In a trade valued at $16,178, the SVP, Chief Legal Officer traded Mersana Therapeutics Inc shares for $2.00 each. Upon closing the transaction, the insider’s holdings decreased to 8,089 shares, worth approximately $0.13 million.
As published in a research note from JP Morgan on March 19, 2024, Mersana Therapeutics Inc [MRSN] has been rated up from an Underweight to a Neutral and the price target has been revised to $5. Analysts at Wedbush upgraded the stock from ‘”a Neutral”‘ to ‘”an Outperform”‘ outlook in a report released in late February. As of February 29, 2024, Guggenheim has increased its “Neutral” rating to a “Buy” for MRSN. Earlier on February 29, 2024, BTIG Research upgraded its rating. Their new recommendation was “a Buy” for MRSN stock which previously was a “a Neutral”.
Analyzing MRSN Stock Performance
During the last five days, there has been a drop of approximately -5.94%. Over the course of the year, Mersana Therapeutics Inc shares have dropped approximately -18.10%. Shares of the company reached a 52-week high of $6.2801 on 03/11/24 and a 52-week low of $1.2200 on 08/14/24. A 50-day SMA is recorded $1.6854, while a 200-day SMA reached $2.8125. Nevertheless, trading volume fell to 0.66 million shares from 0.75 million shares the previous day.
Support And Resistance Levels for Mersana Therapeutics Inc (MRSN)
According to the 24-hour chart, there is a support level at 1.8500, which, if violated, would cause prices to drop to 1.8000. In the upper region, resistance lies at 1.9300. The next price resistance is at 1.9600. RSI (Relative Strength Index) is 51.13 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.0024, which suggests the price will decrease in the coming days. Percent R is at 69.14%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
